UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preferences for cancer treatments: an overview of methods and applications in oncology

Annals of oncology, 2012-05, Vol.23 (5), p.1104-1110

2012

Volltextzugriff (PDF)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

British journal of cancer, 2014-05, Vol.110 (10), p.2462-2471

2014

Volltextzugriff (PDF)

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29

European journal of cancer (1990), 2014-03, Vol.50 (4), p.706-712

2014

Volltextzugriff (PDF)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

British journal of cancer, 2014-10, Vol.111 (9), p.1802-1809

2014

Volltextzugriff (PDF)

Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials

European journal of cancer (1990), 2014-07, Vol.50 (11), p.1916-1924

2014

Volltextzugriff (PDF)

Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients

Supportive care in cancer, 2020-07, Vol.28 (7), p.3399-3407

2020

Volltextzugriff (PDF)

Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials

Lung cancer (Amsterdam, Netherlands), 2012-09, Vol.77 (3), p.537-544

2012

Volltextzugriff (PDF)

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

Gynecologic oncology, 2020-01, Vol.156 (1), p.45-53

2020

Volltextzugriff (PDF)

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

Supportive care in cancer, 2016-01, Vol.24 (1), p.401-408

2016

Volltextzugriff (PDF)

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Annals of oncology, 2014-01, Vol.25 (1), p.143-148

2014

Volltextzugriff (PDF)

e‐TC: Development and pilot testing of a web‐based intervention to reduce anxiety and depression in survivors of testicular cancer

European journal of cancer care, 2017-11, Vol.26 (6), p.e12698-n/a

2017

Volltextzugriff (PDF)

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1756-1764

1996

Volltextzugriff (PDF)

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer

The lancet oncology, 2004-06, Vol.5 (6), p.372-380

2004

Volltextzugriff (PDF)

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer

British journal of cancer, 2010-04, Vol.102 (9), p.1341-1347

2010

Volltextzugriff (PDF)

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer

British journal of cancer, 2006-01, Vol.94 (2), p.208-212

2006

Volltextzugriff (PDF)

Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cows

Journal of dairy science, 2009-09, Vol.92 (9), p.4262-4275

2009

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Annals of oncology, 2005-11, Vol.16 (11), p.1786-1794

2005

Volltextzugriff (PDF)

Doctor-to-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors

Internal medicine journal, 2015-09, Vol.45 (9), p.909-915

2015

Volltextzugriff (PDF)

Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy

Annals of oncology, 2017-08, Vol.28 (8), p.1849-1855

2017

Volltextzugriff (PDF)

A systematic review and meta‐analysis of utility estimates in melanoma

British journal of dermatology (1951), 2018-02, Vol.178 (2), p.384-393

2018

Volltextzugriff (PDF)

What do oncologists think patients with incurable cancer should be told about their prognosis?

Annals of oncology, 2018-11, Vol.29, p.ix136-ix136

2018

Volltextzugriff (PDF)

Historical cross-trial comparisons for competing treatments in advanced breast cancer – An empirical analysis of bias

European journal of cancer (1990), 2010-02, Vol.46 (3), p.541-548

2010

Volltextzugriff (PDF)

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Annals of oncology, 2015-11, Vol.26 (11), p.2280-2286

2015

Volltextzugriff (PDF)

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

British journal of cancer, 2015-04, Vol.112 (8), p.1340-1348

2015

Volltextzugriff (PDF)

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials

Breast (Edinburgh), 2017-02, Vol.31, p.99-104

2017

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(313)
Mit Volltextzugriff
(298)

Publikationsform

Sprache

Englisch
(321)
Japanisch
(24)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Preferences for cancer treatments: an overview of methods and applications in oncology

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials

Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients

Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

e‐TC: Development and pilot testing of a web‐based intervention to reduce anxiety and depression in survivors of testicular cancer

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer

Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cows

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Doctor-to-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors

Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy

A systematic review and meta‐analysis of utility estimates in melanoma

What do oncologists think patients with incurable cancer should be told about their prognosis?

Historical cross-trial comparisons for competing treatments in advanced breast cancer – An empirical analysis of bias

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials

Suchergebnisse filtern